Analyst initiations: Evergreen Solar, Myriad Genetics, Columbia Laboratories

Posted May 28th 2008 12:24PM by Eric Buscemi
Filed under: Analyst Initiations

MOST NOTEWORTHY: Evergreen Solar, Myriad Genetics and Columbia Laboratories were today's noteworthy initiations:

Kaufman Bros. believes Evergreen Solar (NASDAQ: ESLR) is well-positioned to take advantage of a decline in raw material costs because it makes its own wafers on its own equipment. The firm started shares with a Buy rating and $18 target.
Myriad Genetics (NASDAQ: MYGN) was initiated at RBC Capital with an Underperform rating and $37 target and expects negative Phase III results for Flurizan when data is presented in June.
Caris believes Columbia Laboratories (NASDAQ: CBRX) has two potential high value treatments, one to prevent preterm birth and the other to treat primary dysmenorrhea. Shares were initiated with a Buy rating and $11 target.

OTHER INITIATIONS:

McDermott (NYSE: MDR) was initiated with a Buy rating and $70 target at KeyBanc.
Morgan Stanley assumed Canon (NYSE: CAJ) with an Overweight rating.
Polaris Industries (NYSE: PII) was initiated at William Blair with a Market Perform rating.

Tags: CAJ, CBRX, ESLR, initiations, MDR, MYGN, PII